MEDICINE: Large Risk Reduction For Rivaroxaban In Blood Clot Prevention

from Audio Medica News - Medical News Interviews · host Bengt Eriksson, Gothenburg University

Audio Journal of Medicine, December 8th, 2007 Reporting from: American Society of Hematology Annual Meeting, December 8-11 2007, Atlanta Large Risk Reduction For Rivaroxaban In Blood Clot Prevention BENGT ERIKSSON, Gothenburg University REFERENCE: Abstract 6 In a large phase III trial of patients having a hip replacement, the oral anticoagulant rivaroxaban has shown significant benefit when compared to enoxaparin. Derek Thorne heard more from Bengt Eriksson of Gothenburg University.

Episode metadata supplied by the publisher feed · Published Dec 9, 2007

Embed this episode

Attribution link and audio player

NOW PLAYING

MEDICINE: Large Risk Reduction For Rivaroxaban In Blood Clot Prevention

0:00 3:50

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Audio Medica News - Medical News Interviews?

This episode is 3 minutes long.

When was this Audio Medica News - Medical News Interviews episode published?

This episode was published on December 9, 2007.

Can I download this Audio Medica News - Medical News Interviews episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!